Cronos Group, Inc. (CRON)
3.08
-0.09
(-2.84%)
USD |
NASDAQ |
Nov 19, 16:00
3.075
0.00 (0.00%)
After-Hours: 20:00
Cronos Group EPS Diluted (Quarterly) : 0.0372 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0372 |
| June 30, 2026 | 0.0855 |
| March 31, 2026 | 0.036 |
| December 31, 2025 | -0.0047 |
| September 30, 2025 | 0.0674 |
| June 30, 2025 | -0.1031 |
| March 31, 2025 | 0.016 |
| December 31, 2024 | 0.1131 |
| September 30, 2024 | 0.0216 |
| June 30, 2024 | -0.0229 |
| March 31, 2024 | -0.0059 |
| December 31, 2023 | -0.1178 |
| September 30, 2023 | -0.0044 |
| June 30, 2023 | -0.0215 |
| March 31, 2023 | -0.0504 |
| December 31, 2022 | -0.2083 |
| September 30, 2022 | -0.0975 |
| June 30, 2022 | -0.0538 |
| March 31, 2022 | -0.087 |
| December 31, 2021 | -0.3564 |
| September 30, 2021 | 0.2074 |
| June 30, 2021 | -0.4817 |
| March 31, 2021 | -0.4444 |
| December 31, 2020 | -0.3106 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.1849 |
| June 30, 2020 | -0.3065 |
| March 31, 2020 | 0.2025 |
| December 31, 2019 | 0.1792 |
| September 30, 2019 | 1.618 |
| June 30, 2019 | 0.16 |
| March 31, 2019 | 0.3297 |
| December 31, 2018 | -0.0535 |
| September 30, 2018 | -0.0311 |
| June 30, 2018 | 0.0026 |
| March 31, 2018 | -0.0053 |
| December 31, 2017 | 0.0079 |
| September 30, 2017 | 0.008 |
| June 30, 2017 | 0.0008 |
| March 31, 2017 | -0.0076 |
| December 31, 2016 | 0.0075 |
| September 30, 2016 | -0.0027 |
| June 30, 2016 | -0.031 |
| March 31, 2016 | -0.0073 |
| December 31, 2015 | 0.0374 |
| September 30, 2015 | -0.0076 |
| June 30, 2015 | -0.0162 |
| March 31, 2015 | -0.0792 |
| June 30, 2014 | -0.014 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -1.204 |
| Target Group, Inc. (Canada) | -0.0003 |
| XORTX Therapeutics, Inc. | -0.212 |
| NervGen Pharma Corp. | -0.0426 |
| Milestone Pharmaceuticals, Inc. | -0.1831 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.83M |
| Revenue (Quarterly) | 63.45M |
| Total Expenses (Quarterly) | 49.65M |
| Enterprise Value | 440.87M |
| Gross Profit Margin (Quarterly) | 50.31% |
| Profit Margin (Quarterly) | 28.09% |
| Earnings Yield | 5.00% |
| Operating Earnings Yield | 0.86% |
| Normalized Earnings Yield | 5.383 |